61.   She also said the agency considered it prudent to keep Rezulin on the market, as long as it was used according to recommendations and approved labeling.

62.   Sources close to the Justice investigation said that is only one of several options the agency is considering.

63.   The agency considered mifepristone a priority drug, because there is nothing like it being sold in this country.

64.   The agency is also considering modifying the requirement that companies produce long narratives describing their efforts to recruit and hire minority and female workers.

65.   The agency is considering other changes.

66.   The agency is considering requiring manufacturers to indicate on the label the amount of protein and powder in their gloves.

67.   The agency is considering the finding.

68.   The agency must consider each drug individually, she said, and decide whether each is safe enough to be used over the counter.

69.   The agency considers morning-after pills a form of contraception since they block the fertilized egg from implanting into the uterine wall.

70.   The agency is also considering allowing enrollees to bid jointly on federal contracts, thereby increasing the number of companies that may be awarded contracts.